Barclays Maintains Equal-Weight on Adient, Lowers Price Target to $22

Benzinga Newsdesk www.benzinga.com Neutral 64.5%

Neg 0% Neu 64.5% Pos 0%

Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $25 to $22.

Comments

No comments yet. Be the first!